abstract |
The present application describes methods of treating obesity using DGAT-1 inhibitors according to Formula I: n n nincluding all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R 1 , R 2 , R 3 , R 4 and Z are described herein. |